GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

LifeTech Scientific 1302.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.48

-10.84%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.59bn

FY2016FY2025

Net income

CN¥172.0m

FY2016FY2025

Free cash flow

CN¥583.6m

FY2016FY2025

Shareholders' equity

CN¥4.09bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.59bnCN¥1.30bnCN¥1.27bnCN¥1.28bnCN¥1.08bnCN¥747.5mCN¥778.4mCN¥647.9mCN¥476.1mCN¥410.6m
Gross profitCN¥1.19bnCN¥981.4mCN¥995.6mCN¥1.02bnCN¥870.0mCN¥597.2mCN¥622.4mCN¥529.5mCN¥386.3mCN¥321.8m
Research and developmentCN¥282.4mCN¥302.9mCN¥297.9mCN¥242.6mCN¥169.8mCN¥194.7mCN¥164.2mCN¥134.1mCN¥72.4mCN¥66.9m
Operating incomeCN¥215.0mCN¥186.3mCN¥383.3mCN¥437.5mCN¥382.6mCN¥307.8mCN¥219.7mCN¥191.1mCN¥223.7mCN¥127.9m
Net incomeCN¥172.0mCN¥222.4mCN¥263.2mCN¥378.6mCN¥340.4mCN¥251.5mCN¥150.4mCN¥140.9mCN¥190.2mCN¥169.5m
Diluted earnings per share0.040.050.060.090.070.060.030.030.040.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥5.84bnCN¥5.70bnCN¥5.47bnCN¥4.29bnCN¥3.71bnCN¥3.44bnCN¥2.06bnCN¥1.78bnCN¥1.48bnCN¥1.55bn
Cash and short-term investmentsCN¥1.40bnCN¥1.38bnCN¥1.37bnCN¥970.3mCN¥1.72bnCN¥1.33bnCN¥406.2mCN¥416.1mCN¥525.9mCN¥750.9m
Total liabilitiesCN¥1.73bnCN¥1.66bnCN¥1.60bnCN¥895.0mCN¥760.7mCN¥693.7mCN¥710.6mCN¥334.3mCN¥248.8mCN¥534.7m
DebtCN¥4.4mCN¥563.0mCN¥567.6mCN¥152.2mCN¥150.7mCN¥186.0mCN¥353.5mCN¥24.0m—CN¥200.0m
Shareholders' equityCN¥4.09bnCN¥4.07bnCN¥3.92bnCN¥3.38bnCN¥2.91bnCN¥2.72bnCN¥1.34bnCN¥1.44bnCN¥1.23bnCN¥1.01bn
Shares outstanding4,486m4,338m4,391m4,293m4,546m4,445m4,320m4,354m4,349m4,005m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥645.9mCN¥321.5mCN¥486.5mCN¥451.9mCN¥568.9mCN¥394.0mCN¥320.0mCN¥212.2mCN¥180.3mCN¥147.7m
Capital spending−CN¥62.3m−CN¥283.0m−CN¥340.6m−CN¥390.4m−CN¥399.5m−CN¥184.3m−CN¥185.0m−CN¥130.5m−CN¥178.0m−CN¥125.7m
Free cash flowCN¥583.6mCN¥38.5mCN¥145.9mCN¥61.5mCN¥169.4mCN¥209.7mCN¥135.0mCN¥81.7mCN¥2.3mCN¥22.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥689.6mCN¥806.6mCN¥787.5mCN¥650.9mCN¥652.8mCN¥627.7mCN¥744.2mCN¥630.9m
Gross profitCN¥534.7mCN¥606.7mCN¥579.3mCN¥466.1mCN¥515.4mCN¥490.8mCN¥587.5mCN¥503.2m
Operating incomeCN¥9.7mCN¥140.0mCN¥74.9m−CN¥15.7mCN¥202.0mCN¥128.1mCN¥276.7mCN¥178.2m
Net income−CN¥39.4mCN¥107.9mCN¥64.1mCN¥16.8mCN¥205.6mCN¥43.1mCN¥256.2mCN¥128.7m
Diluted earnings per share-0.010.020.010.000.050.010.060.03
Cash from operations—CN¥201.0mCN¥455.0mCN¥218.0mCN¥102.0mCN¥226.0mCN¥259.0mCN¥167.0m
Capital spending—−CN¥38.0m−CN¥25.0m−CN¥15.0m−CN¥181.0m−CN¥117.0m−CN¥115.0m−CN¥126.0m
Free cash flow—CN¥163.0mCN¥430.0mCN¥203.0m−CN¥79.0mCN¥109.0mCN¥144.0mCN¥41.0m
Total assetsCN¥5.53bnCN¥5.84bnCN¥6.21bnCN¥5.70bnCN¥5.61bnCN¥4.70bnCN¥4.75bnCN¥4.29bn
Cash and short-term investmentsCN¥1.44bnCN¥1.40bnCN¥1.62bnCN¥1.38bnCN¥1.21bnCN¥1.18bnCN¥1.15bnCN¥970.3m
DebtCN¥10.6mCN¥4.4mCN¥3.6mCN¥4.4mCN¥771.3mCN¥567.6mCN¥182.5mCN¥177.1m
Shareholders' equityCN¥3.86bnCN¥4.09bnCN¥4.39bnCN¥4.07bnCN¥3.98bnCN¥3.37bnCN¥3.77bnCN¥3.38bn

Financial ratios

Data as of 12 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin74.4%75.3%78.6%79.6%80.8%79.9%
Operating margin14.3%16.0%13.9%34.5%36.3%41.8%
Net margin10.8%17.1%20.8%29.6%31.6%33.6%
Return on equity4.2%6.4%7.8%11.2%11.7%9.2%
Return on assets2.9%4.5%5.6%8.8%9.2%7.3%
Free cash flow yield9.6%9.8%11.4%11.9%12.9%7.9%
Revenue growth5.1%2.9%15.5%18.6%44.1%-4.0%
Earnings growth-33.5%-15.5%-19.1%11.2%35.4%67.2%
Current ratio1.57x2.86x2.90x2.39x3.81x3.13x
Debt to equity0.00x0.00x0.17x0.05x0.06x0.08x
Equity ratio70.1%71.3%71.8%78.6%78.6%79.2%
Interest coverage930.50x110.25x244.19x599.17x128.61x10.44x
R&D as a share of sales17.7%23.2%23.5%19.0%15.8%26.0%
Buybacks as a share of market value-3.4%1.2%-2.3%5.6%-2.3%-2.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.7%16.4%16.0%
Operating income-21.1%-6.9%6.9%
Net income-23.1%-7.3%51.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin74.8%76.8%77.7%78.5%
Operating margin13.8%22.5%26.3%28.0%
Net margin13.6%19.0%22.4%23.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings36.525.535.626.140.066.238.440.735.739.4
Price to sales3.94.37.47.812.622.37.48.814.316.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 8-for-1 split · 12 Jan 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.